Definitive Contract 75N91019C00013
Award Date
9/11/19
Potential Completion Date
9/15/20
Potential Value
$299K
Federal Agency
National Cancer Institute
Awardee
Revela Bio Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02134, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $22,515 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The single year contract runs from February 20, 2024 through February 19, 2025 and utilizes a firm fixed price payment structure. Performance will occur in Bethesda, Maryland. No additional details were provided regarding the original solicitation...
This contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to Reveal Biosciences Inc., a small disadvantaged business based in San Diego, CA. The $386,940 firm-fixed-price contract was issued under a Small Business Innovation Research (SBIR) solicitation focused on developing "Tools and Technologies for Visualizing Multi-Scale Data" to support cancer research and prevention efforts. Reveal Biosciences specializes...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $25,000 purchase order to Revvity Signals Software, Inc. Informatics Division for SOFTWARE. The prime contractor will deliver the requested software products and services over a one-year period of performance from August 1, 2023 through July 31, 2024 under a firm fixed price contract. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Definitive Contract to Reveal Biosciences Inc., a self-certified small disadvantaged business, for SBIR Phase I efforts on the topic of "Artificial Intelligence-Aided Imaging for Cancer Prevention, Diagnosis, and Monitoring." The potential value of the contract is $392,343.00. Reveal Biosciences is a computational pathology company that...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately twelve thousand four hundred eighty-six dollars to Revvity Signals Software, Inc. Informatics Division for software. Revvity Signals Software, Inc. Informatics Division is a subsidiary of Revvity Inc. Medical Imaging, LLC Division. No set aside designation or subcontractors were indicated. The National Cancer Institute...
The Department of Health and Human Services' National Institutes of Health's National Cancer Institute awarded a $17,151 purchase order to Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, to provide unspecified services. The contract has a period of performance from January 5, 2024 through January 4, 2025 and utilizes a firm fixed price contract type. Place of performance will be in Bethesda, Maryland. No additional details regarding scope of work or...
This is a $3,592.40 firm-fixed-price BPA call contract awarded by the National Cancer Institute to Revvity Health Sciences, Inc. The contract is for the delivery of various medical imaging products and services, including automated plate readers, imaging cytometers, liquid scintillation counters, and mass spectrometers. This is a direct federal prime contract award, with no indication of a set-aside designation. Revvity Health Sciences is a for-profit manufacturer and provider of medical imaging...
Revvity Health Sciences, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $22,068 purchase order by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The firm fixed price contract is for maintenance services to be performed between January 1, 2024 and December 31, 2024 at the prime contractor's facility in Hopkinton, Massachusetts. No additional details were provided...
This is a $370,804.00 Phase I Small Business Innovation Research (SBIR) contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH) at the U.S. Department of Health and Human Services (HHS), to Reveal Biosciences Inc. The contract is for the development of an image-based platform to comprehensively de-identify whole slide imaging (WSI) data for cancer research. This was a total small business set-aside contract. Reveal Biosciences is a computational...
This definitive firm fixed price contract from the Department of Health and Human Services National Institutes of Health National Cancer Institute, with a total small business set aside, is for $299,726.89 to Imago Systems Inc. for the development of a novel diagnostic imaging modality for monitoring tumor responses to a hyperthermia immunotherapy as part of the National Cancer Institute's Moonshot initiative. The award stems from Topic 375 of the NIH/CDC SBIR Contract Solicitation PHS 2018-1,...